Labcorp executive awarded shares; stock withheld for taxes

LABCORP HOLDINGS INC. executive Megan D. Bailey received an award of 1,184 shares of common stock on March 26, 2026, as part of a performance award granted on February 7, 2023 for a three-year period ending December 31, 2025.

Rhea-AI Filing Summary

LABCORP HOLDINGS INC. executive Megan D. Bailey received an award of 1,184 shares of common stock on March 26, 2026, as part of a performance award granted on February 7, 2023 for a three-year period ending December 31, 2025. To cover tax withholding obligations, 481 shares were withheld at a price of $268.38 per share, leaving her with 4,851 shares of common stock held directly after these transactions. These movements reflect compensation-related equity awards and associated tax withholding rather than open-market trading.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Bailey Megan D.

Role EVP, Pres, Central Labs & Intl

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,184	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	481	$268.38	$129K

Holdings After Transaction: Common Stock — 4,851 shares (Direct)

Footnotes (2)

1. F1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.
2. F2. Stock withholding to satisfy tax withholding obligations.

Key Figures

Performance share award: 1,184 shares Tax withholding shares: 481 shares Withholding price: $268.38 per share +2 more

5 metrics

Performance share award 1,184 shares Common Stock granted March 26, 2026 under performance award

Tax withholding shares 481 shares Shares withheld to satisfy tax obligations

Withholding price $268.38 per share Price used for tax-related stock withholding

Post-transaction holdings 4,851 shares Common Stock held directly after March 26, 2026 transactions

Tax withholding total shares reported 481 shares TaxWithholdingShares in transaction summary

Key Terms

performance award, stock withholding, tax withholding obligations, grant, award, or other acquisition

4 terms

performance award financial

"pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025"

stock withholding financial

"Stock withholding to satisfy tax withholding obligations."

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations."

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Labcorp (LH) executive Megan D. Bailey report in this Form 4?

Megan D. Bailey reported receiving 1,184 shares of Labcorp common stock as a performance-based award. In the same filing, 481 shares were withheld to satisfy tax obligations, resulting in updated directly held ownership of 4,851 shares after the transactions.

Was the Labcorp (LH) Form 4 transaction an open-market buy or sell?

The Form 4 does not show any open-market buying or selling. It reports a grant of 1,184 shares as a performance award and a tax-related withholding of 481 shares, which is an administrative disposition rather than a discretionary market trade.

How many Labcorp (LH) shares does Megan D. Bailey hold after this Form 4?

After the reported grant and tax withholding, Megan D. Bailey directly holds 4,851 shares of Labcorp common stock. This reflects the net effect of the 1,184-share performance award and the 481-share stock withholding for tax obligations on March 26, 2026.

What was the purpose of the 481 Labcorp (LH) shares withheld in the filing?

The 481 shares were withheld to satisfy tax withholding obligations related to the equity award. The filing characterizes this as stock withholding at $268.38 per share, which is a standard mechanism for paying taxes on vested or earned share-based compensation.

What performance period was tied to Megan D. Bailey’s Labcorp (LH) share award?

The 1,184-share award was earned under a performance award granted on February 7, 2023. It related to performance during the three-year period that ended on December 31, 2025, as described in the filing’s footnote for the acquisition transaction.

Does this Labcorp (LH) Form 4 indicate remaining stock options or derivatives?

The summary data in the filing shows no remaining derivative positions, with an empty derivative section. The reported transactions involve only non-derivative common stock in the form of a performance-based share award and tax withholding, without additional option or warrant details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 12:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bailey Megan D.

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NORTH CAROLINA 27215

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Pres, Central Labs & Intl

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/26/2026		A(1)		1,184	A	$0	5,332	D
Common Stock	03/26/2026		F(2)		481	D	$268.38	4,851	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

2. Stock withholding to satisfy tax withholding obligations.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Megan D. Bailey	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)